Sign in
4

Changes in Ownership

Aardvark Therapeutics, Inc. Filed Acc 0000950170-25-023311

Director acquired 133,364 shares (conversion)

From the SEC's structured data for this filing

Trades in this filing

Chi Jeffrey · Director

Table I: Non-derivative

1 line
Date Transaction Shares Owned after D/I
2025-02-14 Conversion : show line 1 in the form +133,364 133,364 I

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2025-02-14 Conversion : show line 2 in the form Series C Convertible Preferred Stock −1,130,135 0 I
Loading xslF345X05/ownership.xml…